Prevention of shingles: safety and efficacy of live zoster vaccine

References

• AmpofoKSaimanLLaRussaPPersistence of immunity to live attenuated varicella vaccine in healthy adultsClin Infect Dis200234774911830801
   PubMed Web of Science ®Google Scholar
• ArgawTCohenJIKlutchMNucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolatesJ Infect Dis20001811153710720545
   PubMed Web of Science ®Google Scholar
• ArvinAMGershonAALive attenuated varicella vaccineAnn Rev Microbiol199650591008905076
   PubMed Web of Science ®Google Scholar
• ArvinAMGreenbergHBNew viral vaccinesVirology2006344240916364754
   PubMed Web of Science ®Google Scholar
• AsanoYYazakiTMiyataTApplication of a live attenuated varicella vaccine to hospitalized children and its protective effect on spread of varicella infectionBiken J1975183540167708
   PubMedGoogle Scholar
• BergerRFlorentGJustMDecrease of the lymphoproliferative response to varicella-zoster virus antigen in the agedInfect Immunol1981322476163722
   PubMed Web of Science ®Google Scholar
• BerryJDPetersenKLA single dose of gabapentin reduces acute pain and allodynia in patients with herpes zosterNeurology200565444716087911
   PubMed Web of Science ®Google Scholar
• BlackwelderWCDolinRMittalKKA population study of herpesvirus infections and HLA antigensAm J Epidemiol1982115569766280494
   PubMed Web of Science ®Google Scholar
• BowsherDPost-herpetic neuralgia in older patients. Incidence and optimal treatmentDrugs Aging19945411187858367
   PubMed Web of Science ®Google Scholar
• BowsherDThe effects of pre-emptive treatment of postherpetic neuralgia with amitriptyline: a randomized, double-blind, placebo-controlled trialJ Pain Symptom Manage199713327319204652
   PubMed Web of Science ®Google Scholar
• BreuerJVaccination to prevent varicella and shinglesJ Clin Pathol200154743711577118
   PubMed Web of Science ®Google Scholar
• BrissonMEdmundsWJGayNJModelling the impact of immunization on the epidemiology of varicella zoster virusEpidemiol Infect20001256516911218215
   PubMed Web of Science ®Google Scholar
• BrissonMGayNJEdmundsExposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpoxVaccine2002202500712057605
   PubMed Web of Science ®Google Scholar
• BrissonMEdmundsWJGayNJVaricella vaccination: impact of vaccine efficacy on the epidemiology of VZVJ Med Virol200370S31712627484
   PubMed Web of Science ®Google Scholar
• BrunellPAArgawTChickenpox attributable to a vaccine virus contracted from a vaccine with zosterPediatrics2000106E2810920184
   PubMed Web of Science ®Google Scholar
• ChapmanRSCrossKWFlemingDMThe incidence of shingles and its implications for vaccination policyVaccine2003212541712744889
   PubMed Web of Science ®Google Scholar
• ChenJJZhuZGershonAAMannose 6-phosphate receptor dependence of varicella zoster virus infection in vitro and in the epidermis during varicella and zosterCell20041199152615620351
   PubMed Web of Science ®Google Scholar
• CohrsRJGildenDHGomiYComparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virusJ Virol20068020768216474115
   PubMed Web of Science ®Google Scholar
• CoplanPMSchmaderKNikasADevelopment of a measure of the burden of pain due to herpes zoster and postherpetic neuralgia for prevention trials: adaptation of the brief pain inventoryJ Pain200453445615336639
   PubMed Web of Science ®Google Scholar
• DonahueJGChooPWMansonJEThe incidence of herpes zosterArch Intern Med1995155160597618983
   PubMed Web of Science ®Google Scholar
• DubinskyRMKabbaniHEl-ChamiZPractice parameter: treatment of postherpetic neuralgiaNeurology2004639596515452284
   PubMed Web of Science ®Google Scholar
• EllisRWVaricella vaccineVaccine199513138788578813
   PubMed Web of Science ®Google Scholar
• FristadIBardsenAKnudsenGCProdromal herpes zoster--a diagnostic challenge in endodonticsInt Endod J20023510121612653320
   PubMed Web of Science ®Google Scholar
• GelbLDDohnerDEGershonAAMolecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adultsJ Infect Dis1987155633403029239
   PubMed Web of Science ®Google Scholar
• GershonAALive attenuated varicella vaccineAnn Rev Med19873841503034136
   PubMed Web of Science ®Google Scholar
• GiddingHFBrissonMMacintyreCRModelling the impact of vaccination on the epidemiology of varicella zoster virus in AustraliaAust N Z J Public Health2005295445116366065
   PubMed Web of Science ®Google Scholar
• GildenDHDuelandANCohrsRPreherpetic neuralgiaNeurology1991411215181866008
   PubMed Web of Science ®Google Scholar
• GildenDHBeinlichBRRubinstienEMVaricella-zoster virus myelitis: an expanding spectrumNeurology1994441818237936229
   PubMed Web of Science ®Google Scholar
• GildenDHCohrsRJMahalingamRClinical and molecular pathogenesis of varicella virus infectionViral Immunol2003162435814583142
   PubMed Web of Science ®Google Scholar
• GildenDHVaricella-zoster virus vaccine – grown-ups need it, tooN Engl J Med20053522344615930426
   PubMed Web of Science ®Google Scholar
• GildenDHCohrsRJMahalingamRVZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapyNeurology20056421515642898
   PubMed Web of Science ®Google Scholar
• GoldmanGSCost-benefit analysis of universal varicella vaccination in the U.S. taking into account the closely related herpes-zoster epidemiologyVaccine20052333495515837242
   PubMed Web of Science ®Google Scholar
• GomiYSunamachiHMoriYComparison of the complete DNA sequences of the Oka varicella vaccine and its parental virusJ Virol200276114475912388706
   PubMed Web of Science ®Google Scholar
• GroseCVaricella vaccination of children in the United States: assessment after the first decade 1995–2005J Clin Virol200533899515911422
   PubMed Web of Science ®Google Scholar
• HawramiKBreuerJAnalysis of United Kingdom wild-type strains of varicella-zoster virus: differentiation from the Oka vaccine strainJ Med Virol1997536029298733
   PubMed Web of Science ®Google Scholar
• HaywardARHerbergerMLymphocyte responses to varicella zoster virus in the elderlyJ Clin Immunol1987717483033012
   PubMed Web of Science ®Google Scholar
• HaywardALevinMWolfWVaricella-zoster virus-specific immunity after herpes zosterJ Infect Dis199116387351849165
   PubMed Web of Science ®Google Scholar
• HaywardAVillanuebaECosynsMVaricella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccineJ Infect Dis199216626041321860
   PubMed Web of Science ®Google Scholar
• InsingaRPItzlerRFPellissierJMThe incidence of herpes zoster in a United States administrative databaseJ Gen Intern Med2005207485316050886
   PubMed Web of Science ®Google Scholar
• KrausePRKlinmanDMVaricella vaccination: evidence for frequent reactivation of the vaccine strain in healthy childrenNat Med20006451410742154
   PubMed Web of Science ®Google Scholar
• KuCCZerboniLItoHVaricella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alphaJ Exp Med20042009172515452178
   PubMed Web of Science ®Google Scholar
• KuterBJWeibelREGuessHAOka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studiesVaccine1991964371659052
   PubMed Web of Science ®Google Scholar
• LaRussaPLunguOHardyIRestriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolatesJ Virol1992661016201346169
   PubMed Web of Science ®Google Scholar
• LevinMJBarberDGoldblattEUse of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effectJ Infect Dis1998178suppl 1S109129852987
   PubMed Web of Science ®Google Scholar
• MillerAESelective decline in cellular immune response to varicella-zoster in the elderlyNeurology19803058276247671
   PubMed Web of Science ®Google Scholar
• MillerLHBrunellPAZoster reinfection or activation of latent virus? Observations on the antibody responseAm J Med19704948034320119
   PubMed Web of Science ®Google Scholar
• NagasakoEMJohnsonRWGriffinDRGeographic and racial aspects of herpes zosterJ Med Virol200370suppl 120312629639
   PubMed Web of Science ®Google Scholar
• NikkelsAFSadzot-DelvauxCPierardGEAbsence of intercellular adhesion molecule 1 expression in varicella zoster virus-infected keratinocytes during herpes zoster: another immune evasion strategy?Am J Dermatopathol200426273214726820
   PubMed Web of Science ®Google Scholar
• OsterGHardingGDukesEPain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based surveyJ Pain200563566315943957
   PubMed Web of Science ®Google Scholar
• OxmanMNLevinMJJohnsonGRA vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsN Eng J Med2005352227184
   PubMed Web of Science ®Google Scholar
• ProsserLARayGTO’BrienMPreferences and willingness to pay for health states prevented by pneumococcal conjugate vaccinePediatrics20041132839014754939
   PubMed Web of Science ®Google Scholar
• ScottFTJohnsonRWLeedham-GreenMThe burden of herpes zoster: a prospective population based studyVaccine20062413081416352376
   PubMed Web of Science ®Google Scholar
• SoongWSchultzJCPateraACInfection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolatesJ Virol20007418647010644359
   PubMed Web of Science ®Google Scholar
• SperberSJSmithBVHaydenFGSerologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccineAntiviral Res199217213221314536
   PubMed Web of Science ®Google Scholar
• TakahashiMOtsukaTOkunoYLive vaccine used to prevent the spread of varicella in children in hospitalLancet197421288904139526
   PubMed Web of Science ®Google Scholar
• TakahashiMOkunoYOtsukaTDevelopment of a live attenuated varicella vaccineBiken J1975182533167707
   PubMedGoogle Scholar
• ThomasSLWheelerJGHallAJContacts with varicella or children and protection against herpes zoster in adults: a case-control studyLancet20023606788212241874
   PubMed Web of Science ®Google Scholar
• TyringSBarbarashRANahlikJEFamciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgiaAnn Intern Med199512389967778840
   PubMed Web of Science ®Google Scholar
• TyringSKBeutnerKRTuckerBAAntiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and olderArch Fam Med20009863911031393
   PubMedGoogle Scholar
• VolpiAVaricella immunization and herpes zosterHerpes2005125916393520
   PubMedGoogle Scholar
• WatsonBRothsteinEBernsteinHSafety and cellular and humoral immune responses of a booster dose of varicella vaccine 6 years after primary immunizationJ Infect Dis1995172217197797914
   PubMed Web of Science ®Google Scholar
• WeinsteinMCSiegelJEGoldMRRecommendations of the panel on cost-effectiveness in health and medicineJAMA19962762538
   Web of Science ®Google Scholar
• WhitleyFJWeissHGnannJWJrAcyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trialAnn Intern Med1996125376838702088
   PubMed Web of Science ®Google Scholar
• WoodMJJohnsonRWMcKendrickMWA randomized trial of acyclovir for 7 or 21 days with and without prednisolone for treatment of acute herpes zosterN Eng J Med1994330896900
   PubMed Web of Science ®Google Scholar
• WoodMJKayRDworkinRHOral acyclovir accelerates pain resolution in herpes zoster: A meta-analysis of placebo-controlled trialsClin Infect Dis19962234178838194
   PubMed Web of Science ®Google Scholar
• ZoulekGLaboratory markers of immunity to varicella-zoster virusPostgrad Med J198561suppl47523014477
   PubMed Web of Science ®Google Scholar